Regeneron Pharmaceuticals Inc.'s victory against Amgen Inc. over anticompetitive drug bundling reinforces the necessity for ...

IIFL Capital has given an Add rating on Gland Pharma with a target price of Rs 1,650. According to the brokerage, Gland ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

Taken together, the reports stand as an indictment of the entire programmatic ecosystem. Critics say the unsuitable ...

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

The average of price targets set by Wall Street analysts indicates a potential upside of 31.1% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, ...

India’s Pharma Sector has registered a 7.8 percent year-on-year growth in April 2025, driven by strong demand and new ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Multiple witnesses in Sean "Diddy" Combs' sweeping federal sex-crimes trial testified on years of alleged physical, sexual and emotional abuse.